UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period ended SeptemberJune 30, 20172020

( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________

Commission File number 0-24115000-24115

WORLDS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware22-1848316
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)

11 Royal Road
Brookline, MA 02445
(Address of Principal Executive Offices)


(617) 725-8900
(Registrant's Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,  or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”filer”, “accelerated filer”, “smaller reporting company”, and “smaller reporting“emerging growth company” in Rule 12b-2 of the Exchange Act. (check one):

(Check One):

Large Accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
(Do not check if a smaller reporting company) 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

 

As of October 30, 2017, 246,773,331August 11, 2020, 56,814,833 shares of the Issuer's Common Stock were outstanding. 

  

  

Worlds Inc.

 

Table of Contents

  Page
Balance Sheets as of SeptemberJune 30, 2017 (Unaudited)2020 (unaudited) and December 31, 2016 (Audited)2019 (audited) 2 
Statements of Operations for the six and three months ended June 30, 2020 and nine months ended September 30, 2017 and 2016 (Unaudited)2019 (unaudited) 3 
Statements of Cash FlowsStockholders’ Deficit for the ninesix months ended SeptemberJune 30,  20172019 and 2016 (Unaudited)2020 (unaudited) 4 
Notes to Financial Statements of Cash Flows for the six months ended June 30, 2020 and 2019 (unaudited) 5 
Notes to Financial Statements6

 

 (1)1 
Table of Contents   

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

 

Worlds Inc.    
Balance Sheets    
June 30, 2020 and December 31, 2019    
  Unaudited Audited
  June 30, 2020 December 31, 2019
     
ASSETS:        
Current Assets        
Cash and cash equivalents $1,038,759  $1,570,844 
Total Current Assets  1,038,759   1,570,844 
         
Convertible Note Receivable - related party  200,000   200,000 
Accrued interest receivable - related party  10,111   3,033 
Total assets $1,248,870  $1,773,877 
         
         
LIABILITIES AND STOCKHOLDERS' DEFICIT:        
Current Liabilities        
Accounts payable $799,024  $840,674 
Accrued expenses  1,636,540   1,604,911 
Notes payable exceeding statute of limitations  773,279   773,279 
         
Total Current Liabilities  3,208,843   3,218,864 
         
         
Total Liabilities  3,208,843   3,218,864 
         
Stockholders' Deficit        
Common stock (Par value $0.001 authorized 250,000,000 shares, issued and outstanding 56,814,833 at June 30, 2020 and December 31, 2019, respectively)  56,815   56,815 
Additional paid in capital  41,122,525   40,897,142 
Common stock - warrants  1,206,913   1,206,913 
Accumulated deficit  (44,346,226)  (43,605,857)
Total stockholders deficit  (1,959,973)  (1,444,987)
         
Total Liabilities and Stockholders' Deficit $1,248,870  $1,773,877 
         
The accompanying notes are an integral part of these financial statements

Worlds Inc.    
Balance Sheets    
September 30, 2017 and December 31, 2016    
  Unaudited Audited
  September 30, 2017 December 31, 2016
ASSETS:        
Current Assets        
Cash and cash equivalents $37,976  $93,378 
Due from related party  10,095   —   
         
Total Current Assets  48,071   93,378 
         
Total assets $48,071  $93,378 
         
         
LIABILITIES AND STOCKHOLDERS' DEFICIT:        
Current Liabilities        
Accounts payable $797,908  $797,908 
Accrued expenses  2,691,762   2,545,672 
Due to related party  —     5,053 
Notes payable  773,279   773,279 
Notes Payable  25,000   750,000 
         
Total Current Liabilities  4,287,949   4,871,912 
         
Long Term Liabilities        
Notes payable  725,000   —   
         
Total Long Term Liabilities  725,000   —   
         
Stockholders' (Deficit)        
         
Common stock (Par value $0.001 authorized 250,000,000 shares, issued and outstanding 246,773,331 and 210,156,148 at September 30, 2017 and December 31, 2016, respectively)  246,773   210,156 
Common stock subscribed but not yet issued (0 at September 30, 2017 and 11,350,000 at December 31, 2016)  —     11,350 
Additional paid in capital  35,464,894   35,171,780 
Common stock-warrants  1,206,913   1,206,913 
Accumulated deficit  (41,883,459)  (41,378,732)
Total stockholders deficit  (4,964,877)  (4,778,533)
         
Total Liabilities and stockholders' deficit $48,071  $93,378 
         
         
The accompanying notes are an integral part of these financial statements

 

 

 (2)2
Table of Contents

Worlds Inc.        
Statements of Operations        
For the Six and Three Months Ended June 30, 2020 and 2019        
         
 Unaudited Unaudited
 Six Months Ended June 30 Three Months Ended June 30
  2020 2019 2020 2019
Revenues                
Revenue $—    —    $—    —   
Total Revenue  —     —     —     —   
                 
Cost and Expenses                
                 
Cost of Revenue  —     —     —     —   
                 
Gross Profit/(Loss)  —     —     —     —   
                 
Option expense  187,546   54,471   106,467   35,298 
Selling, General & Admin.  414,828   346,672   242,898   161,073 
Salaries and related  107,236   102,265   54,570   50,908 
Operating loss  (709,610)  (503,408)  (403,935)  (247,279)
                 
Other Income (Expense)                
Interest income  7,078   —     3,539   —   
Interest expense  (37,837)  (8,015)  (18,918)  —   
Net Income/(Loss) $(740,369) (511,423) $(419,314) (247,279)
                 
Weighted Average Loss per share $(0.01) (0.01) $(0.01)  **  
                 
Weighted Average Common Shares Outstanding (reflecting the reverse stock split)  56,814,833   56,814,833   56,814,833   56,814,833 
                
**=less than $0.01                
                 
The accompanying notes are an integral part of these financial statements

3
Table of Contents

Worlds Inc.            
Statement of Stockholders' Deficit            
For the Six Months Ended June 30, 2019 and 2020            
             
             
  Common Common Additional Common Accumulated Total
  stock stock Paid-in stock Deficit stockholders'
  Shares Amount capital Warrants   deficit
             
 Balances, December 31, 2018  56,814,833   56,815   40,512,516   1,206,913   (42,371,386)  (595,142)
                         
Fair value of stock options  —     —     54,471   —     —     54,471 
                         
 Net Income/(Loss)  —     —     —     —     (511,423)  (511,423)
                         
 Balances, June 30, 2019 (unaudited)  56,814,833   56,815   40,566,987   1,206,913   (42,882,809)  (1,052,094)
                         
 Balances, December 31, 2019  56,814,833   56,815   40,897,142   1,206,913   (43,605,857)  (1,444,987)
                         
 Fair value of stock options  —     —     187,546   —     —     187,546 
                         
 Imputed interest  —     —     37,837   —     —     37,837 
                         
 Net Income/(Loss)  —     —     —     —     (740,369)  (740,369)
                         
 Balances, June 30, 2020 (unaudited)  56,814,833   56,815   41,122,525   1,206,913   (44,346,226)  (1,959,973)
                         
The accompanying notes are an integral part of these financial statements

4
Table of Contents

Worlds Inc.    
Statements of Cash Flows    
Six Months Ended June 30, 2020 and 2019    
   
  Unaudited Unaudited
  6/30/20 6/30/19
Cash flows from operating activities:        
Net gain/(loss) $(740,369) $(511,423)
Adjustments to reconcile net loss to net cash (used in) operating activities        
Fair value of stock options issued  187,546   54,471 
Imputed interest  37,837   —   
Accounts payable and accrued expenses  (10,021)  (374,166)
Net cash (used in) operating activities:  (525,007)  (831,118)
         
Cash flows from financing activities        
Accrued interest receivable - related party  (7,078)  —   
Repayment of notes payable  —     (600,000)
Repayment of notes payable related party  —     (150,000)
Net cash provided by financing activities  (7,078)  (750,000)
         
Net increase/(decrease) in cash and cash equivalents  (532,085)  (1,581,118)
         
Cash and cash equivalents, including restricted, beginning of year  1,570,844   3,846,120 
         
Cash and cash equivalents, including restricted, end of period $1,038,759  $2,265,002 
         
Non-cash financing activities        
         
Supplemental disclosure of cash flow information:        
Cash paid during the year for:        
Interest $—    $189,118 
Income taxes $—    $—   
         
The accompanying notes are an integral part of these financial statements

5 
Table of Contents   

  

 

Worlds Inc.         
Statements of Operations         
For the Three and Nine Months Ended September 30, 2017 and 2016       
  Unaudited  Unaudited
  Nine months ended September 30  

Three months ended

September 30

  2017 2016  2017 2016
Revenues                 
Revenue $—    $—     $—    $—   
                  
Total Revenue  —     —      —     —   
                  
                  
Cost and Expenses                 
                  
Cost of Revenue  —     —      —     —   
                  
Gross Profit/(Loss)  —     —      —     —   
                  
                  
Warrant expense  —     1,109,044    —     1,109,044 
Option expense  —     —      —     —   
Selling, General & Admin.  332,166   539,256    78,797   136,448 
Salaries and related  192,163   176,635    64,054   60,172 
                  
Operating loss  (524,329)  (1,824,935)   (142,852)  (1,305,664)
                  
                  
Other Income (Expense)                 
Gain on sale of marketable securities  58,655   —      58,655   —   
Gain (Loss) on change in fair value of derivative liability  —     (364,191)   —     71,860 
Interest Expense  (33,658)  (75,796)   (11,342)  (21,536)
Loss on conversion of payable to common stock  (5,394)  —      —     —   
Net Income/(Loss) $(504,726) $(2,264,922)  $(95,540) $(1,255,340)
                  
Weighted Average Loss per share $ **  $(0.02)    **   $(0.01)
Weighted Average Common Shares Outstanding  245,047,227   145,427,831    246,773,331   113,268,877 
                  
**=less than $0.01                 
                  
The accompanying notes are an integral part of these financial statements

(3)
Table of Contents

Worlds Inc.    
Statements of Cash Flows    
Nine Months Ended September 30, 2017 and 2016    
   
  Unaudited Unaudited
  9/30/17 9/30/16
Cash flows from operating activities:        
Net gain/(loss) $(504,726) $(2,264,922)
Adjustments to reconcile net loss to net cash (used in) operating activities        
Fair value of warrants issued  —     1,109,044 
Amortization of discount to note payable  —     (12,334)
Changes in fair value of derivative liabilities  —     415,706 
Accounts payable and accrued expenses  146,089   124,541 
Due from/to related party  (15,148)  (36,766)
Net cash (used in) operating activities:  (373,785)  (664,731)
         
         
Cash flows from financing activities        
Proceeds from issuance of note payable  —     290,000 
Proceeds from issuance of convertible note payable  —     156,500 
Cash paid to repurchase convertible note payable      (110,257)
Proceeds from issuance of common stock      350,000 
Proceeds from exercise of warrants  292,800   —   
Issuance of common stock as payment for account payable  25,582   —   
Net cash provided by financing activities  318,382   686,243 
         
Net increase/(decrease) in cash and cash equivalents  (55,404)  21,512 
         
Cash and cash equivalents, including restricted, beginning of year  93,378   26,298 
         
Cash and cash equivalents, including restricted, end of period $37,976  $47,812 
         
Non-cash financing activities        
Issuance of 54,963,098 shares of common stock to retire convertible notes payable  —     384,159 
         
Supplemental disclosure of cash flow information:        
Cash paid during the year for:        
Interest $—    $—   
Income taxes $—    $—   
         
The accompanying notes are an integral part of these financial statements

(4)
Table of Contents

Worlds Inc.

NOTES TO FINANCIAL STATEMENTS

NineSix Months Ended SeptemberJune 30, 20172020

(Unaudited)

NOTE 1 – GOING CONCERN

As reflected in the accompanying financial statements, the Company has a working capital deficiency of $2,170,084 and a stockholder’s deficiency of $1,959,973 and used $525,007 of cash in operations for the six months ended June 30, 2020. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Management believes that the actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

 

NOTE 12 – DESCRIPTION OF BUSINESS AND SUMMARY OF ACCOUNTING POLICIES

 

Description of Business

 

On May 16, 2011, the Company transferred, through a spin-off to its then wholly owned subsidiary, Worlds Online Inc. (currently called MariMed Inc.), the majority of its operations and related operational assets. The Company retained its patent portfolio which it intends to continue to increase and to more aggressively enforce against alleged infringers. The Company also entered into a License Agreement with Worlds Online Inc. to sublicense its patented technologies.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP"), which contemplates continuation of the Company as a going concern.. The Company has always been considered a developmental stage business, has incurred significant losses since its inception and has had minimal revenues from operations. The Company will require substantial additional funds for development and enforcement of its patent portfolio. There can be no assurance that the Company will be able to obtain the substantial additional capital resources to pursue its business plan or that any assumptions relating to its business plan will prove to be accurate. The Company has not been able to generate sufficient revenue or obtain sufficient financing which has had a material adverse effect on the Company, including requiring the Company to reduce operations. These factors raise substantial doubt about the Company's ability to continue as a going concern. As the Company has focused its attention on increasing its patent portfolio and enforcing it, the Company has been operating at a significantly reduced capacity, with only one full time employee and using consultants to perform any additional work that may be required.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

6
Table of Contents

 

Cash and Cash Equivalents

 

Cash and cash equivalents includes highly liquid money market instruments, which have original maturities of three months or less at the time of purchase.

Due to Related Party

Due to related party is comprised of cash payments made by Worlds Online Inc. on behalf of Worlds Inc. for shared operating expenses.

(5)
Table of Contents

 

 

Revenue Recognition

 

Effective forJanuary 1, 2018, the Company adopted ASC 606. There was no impact in adopting ASC 606 as the Company has no revenue at this time. In the second quarter of 2011, the Company spun off its online businesses to MariMed Inc. (then called Worlds Online, Inc.). The Company’s sources of revenue after the spin off arespinoff was expected to be from sublicenses of the patented technology by Worlds Online and any revenue that may be generated from enforcing its patents. The Company recognizes revenue when all ofby applying the following criteria are met: evidence of an arrangement exists such assteps: (1) identify the contract with a signed agreement or contract or a final court decision, delivery has occurred,customer; (2) identify the price is fixed or determinable, and collectability is reasonable assured. This will usually beperformance obligations in the form of a receipt of a customer’s acceptance indicatingcontract; (3) determine the product has been completedtransaction price; (4) allocate the transaction price to their satisfaction except for development workeach performance obligation in the contract; and service(5) recognize revenue whichwhen each performance obligation is recognized when the services have been performed.satisfied.

 

Research and Development Costs

 

Research and development costs are charged to operations as incurred.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is provided on a straight line basis over the estimated useful lives of the assets ranging from three to five years. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income. Maintenance and repairs are charged to expense in the period incurred.

 

Impairment of Long Lived Assets

 

The Company evaluates the recoverability of its fixed assets and other assets in accordance with section 360-10-15 of the FASB Accounting Standards Codification for disclosures about Impairment or Disposal of Long-Lived Assets. Disclosure requires recognition of impairment of long-lived assets in the event the net book value of such assets exceeds its expected cash flows. If so, it is considered to be impaired and is written down to fair value, which is determined based on either discounted future cash flows or appraised values. The Company adopted the statement on inception. No impairments of these types of assets were recognized during 20162019 and 2015 or the first nine months of 2017.2018.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance set forth in section 718-10 of the FASB Accounting Standards Codification for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

7
Table of Contents

  

Income Taxes

 

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

(6)
Table of Contents

 

 

Notes Payable

 

The Company has $773,279 in short term notes outstanding at SeptemberJune 30, 20172020 and December 31, 2016.2019. These are old notes payable for which the statute of limitations has passed and therefore the Company does not expect it will ever have to repay those notes.

The Company has an additional $725,000 in long term notes and $25,000 in short term notes outstanding at September 30, 2017. The Company had $750,000 in short term notes outstanding at December 31, 2016. All of the notes were extended during the quarter.

 

Comprehensive Income (Loss)

 

The Company reports comprehensive income and its components following guidance set forth by section 220-10 of the FASB Accounting Standards Codification which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. There were no items of comprehensive income (loss) applicable to the Company during the period covered in the financial statements.

 

Loss Per Share

 

Net loss per common share is computed pursuant to section 260-10-45 of the FASB ASC. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. As of SeptemberJune 30, 2017,2020 and June 30, 2019, there were 26,250,00011,020,000 options and no4,380,000 warrants outstanding whose effect is anti-dilutive and not included in diluted net loss per share for SeptemberJune 30, 2017.2020 or for June 30, 2019. The options and warrants may dilute future earnings per share.

 

Commitments and Contingencies

 

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

During 2000 the Company was involved in a lawsuit relating to unpaid consulting services. In April, 2001 a judgment against the Company was rendered for approximately $205,000. As of SeptemberJune 30, 2017,2020, and December 31, 20162019 the Company recorded a reserve of $205,000 for this lawsuit, which is included in accrued expenses in the accompanying balance sheets.

 (7)8 
Table of Contents   

  

 

Risk and Uncertainties

 

The Company is subject to risks common to companies in the technology industries, including, but not limited to, litigation, development of new technological innovations and dependence on key personnel.

 

Off Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements.

 

Uncertain Tax Positions

 

The Company did not take any uncertain tax positions and had no adjustments to unrecognized income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the year ended December 31, 2016.2019.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
•  Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
•  Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
•  Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, other receivables, accounts payable & accrued expenses, due to related party, notes payable and notes payables, approximate their fair values because of the short maturity of these instruments. The Company's convertible notes payable are measured at amortized cost.

 

The Company accounts for its derivative liabilities, at fair value, on a recurring basis underWarrant and option expense was measured by using level 3. See Note 5.

3 valuation.

 (8)9 
Table of Contents   

   

 

Embedded Conversion Features 

 

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.

 

Derivative Financial Instruments

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.

 

For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Subsequent Events

The Company evaluated for subsequent events through the issuance date of the Company’s financial statements.

 

Recent Accounting Pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

 The Company accounts for stock-based compensation for employees and directors in accordance with Accounting Standards Codification 718, Compensation (“ASC 718”) as issued by the Financial Accounting Standards Board (“FASB”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations. The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.

In February 2016, the FASB issued Accounting Standards Update 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted the new lease guidance effective January 1, 2019. The Company is not a party to any leases and therefore is not showing any asset or liability related to leases in the current period or prior periods.  

 (9)10 
Table of Contents   

  

 NOTE 2 - GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. Since its inception, the Company has had periods where it had only minimal revenues from operations. There can be no assurance that the Company will be able to obtain the additional capital resources to fully implement its business plan or that any assumptions relating to its business plan will prove to be accurate. The Company is pursuing sources of additional financing and there can be no assurance that any such financing will be available to the Company on commercially reasonable terms, or at all. Any inability to obtain additional financing will likely have a material adverse effect on the Company, including possibly requiring the Company to completely reduce and/or cease operations.

 

These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

NOTE 3 - NOTES PAYABLE

Notes payable at June 30, 2020 consist of the following:  
Unsecured note payable bearing 8% interest,    
entire balance of principal and unpaid interest due on demand $124,230 
Unsecured note payable bearing 10% interest,    
entire balance of principal and unpaid interest due on demand $649,049 
Total notes $773,279 
2020 $773,279 
2021 $-0- 
2022 $-0- 
2023 $-0- 
2024 $-0- 
  $773,279 

The Company imputed interest of $37,837 on the notes during the six months ended June 30, 2020. The Company repaid the $600,000 in notes payable and $150,000 in notes payable related party with accrued interest totaling $189,118 during the six months ended June 30, 2019. 

NOTE 4 - EQUITY

All common stock numbers and exercise prices in this Note are reflected on a post reverse split (5 to 1) basis. As a result of the reverse split on February 9, 2018, the Company had to issue an additional 167 shares due to rounding.

 

During the ninesix months ended SeptemberJune 30, 20172020, the Company receivedrecorded an additional $292,800 uponoption expense of $187,546 representing the exercise of 24,400,000 warrants to purchase 24,400,000 sharesamortization of the Company’s common stock at $0.012 per share. During the nine months ended September 30, 2017 the Company issued 750,000 sharesvalue of the Company’s common stock as payment for services rendered, an aggregate value of $18,000. The expense was recordedoptions issued in a prior year and the shares were listed as common stock subscribed but2018 that have not yet issued until the shares were issued during the nine months ended September 30, 2017.vested.

 

During the ninesix months ended SeptemberJune 30, 2016,2019, the Company issued 35,000,000 sharesrecorded an option expense of common stock at a price of $0.01 per share raising $350,000. In connection with this raise,$54,471 representing the Company issued 35,000,000 warrants with each to purchase one share of common stock at a price of $0.012. Allamortization of the warrantsvalue of the options issued in 2018 that have been exercised as of September 30, 2017.not yet vested. 

 

During the nine months ended September 30, 2016, the Company issued 54,963,098 shares of common stock by converting $384,159 of the principal of convertible notes payable.

Stock Warrants and Options
Stock warrants/options outstanding and exercisable on June 30, 2020 are as follows:
 
Exercise Price per Share Shares Under Option/warrant Remaining Life in Years
Outstanding    
$0.325   3,500,000   3.58 
$0.15   5,220,000   2.25 
$0.15   580,000   0.45 
$0.05   200,000   2.45 
$0.30   200,000   2.45 
$0.25   5,000,000   3.17 
$0.24   800,000   3.17 
Exercisable          
$0.325   3,500,000   3.58 
$0.15   5,220,000   2.25 
$0.15   580,000   0.45 
$0.05   200,000   2.45 
$0.30   200,000   2.45 
$0.25   3,500,000   3.17 
$0.24   800,000   3.17 

 

NOTE 4 - NOTES PAYABLE

Notes payable at September 30, 2017 consist of the following:  
Unsecured note payable to a shareholder bearing 8% interest.    
Entire balance of principal and unpaid interest due on demand $124,230 
Unsecured note payable to a shareholder bearing 10% interest    
Entire balance of principal and unpaid interest due on demand $649,049 
Promissory notes $700,000 
Notes Payable - related party $50,000 
Total notes $1,523,279 
2017 $773,279 
2018 $25,000 
2019 $725,000 
2020 $-0- 
2021 $-0- 
  $1,523,279 

We issued promissory notes in the amount of $290,000 during the nine months ended September 30, 2016. The promissory notes carry a 6% annual interest rate. All of the promissory notes had reached their maturity date and extension agreements have been signed for all of the $750,000 in notes. The holders of the promissory notes shall receive repayment in the full face amount of the note from the initial $750,000 the Company actually receives from the net proceeds of its patent infringement claim(s) or from the net proceeds of a public offering. In addition the holder shall receive a preferred return (i) in an amount equal to up to 200% of the initial face amount of the note out of available cash by sharing with all other investors in this series of notes in the allocation of 50% of the available cash received by the Company from $2M - $4M and (ii) in an amount equal to up to 100% of the initial face amount of the note out of available cash by sharing with all other investors in this series of notes in the allocation of 25% of the available cash received by the Company from $4M - $6M. In other words, if the Company collects $6M in the net proceeds of available cash, the holder will receive a return equal to 400% of its investment.  

 (10)11 
Table of Contents   

NOTE 5 – STOCK OPTIONS

The Company issued 25,000,000 shares of common stock with an exercise price of $0.03 per share during the nine months ended September 30, 2017 and no stock options were exercised during the nine months ended September 30, 2017.

No stock options were issued during the nine months ended September 30, 2016 and no stock options were exercised during the nine months ended September 30, 2016. 

Stock Warrants and Options
Stock warrants/options outstanding and exercisable on September 30, 2017 are as follows:
 
Exercise Price per Share Shares Under Option/warrant Remaining Life in Years
 Outstanding         
$0.19   200,000   0.25 
$0.155   200,000   1.25 
$0.14   250,000   1.25 
$0.11   300,000   2.75 
$0.03   300,000   2.75 
$0.03   25,000,000   5.00 

Exercise Price per Share Shares Under Option/warrant Remaining Life in Years
  Exercisable         
$0.19   200,000   0.25 
$0.155   200,000   1.25 
$0.14   250,000   1.25 
$0.11   300,000   2.75 
$0.03   300,000   2.75 

 

NOTE 65 - COMMITMENTS AND CONTINGENCIES

 

The Company is committed to an employment agreement with its President and CEO, Thom Kidrin. The agreement, dated as of August 30, 2012,28, 2018, is for five years with a one-year renewal option held by Mr. Kidrin.  The agreement provides for a base salary of $175,000,$200,000, which increases 10% on September 1 of each year; a monthly car allowance of $500; an annual bonus equal to 2.5% of Pre-Tax Income (as defined in the agreement); an additional bonus as follows: $75,000, if Pre-Tax Income for the year is between 150% and 200% of the prior fiscal year’s Pre-Tax Income or (B) $100,000, if Pre-Tax Income for the year is between 201% and 250% of the prior fiscal year’s Pre-Tax Income or (C) $200,000, if Pre-Tax Income for the year is 251% or greater than the prior fiscal year’s Pre-Tax Income, but in no event shall this additional bonus exceed five (5%) percent of Pre-Tax Income for such year; payment of up to $10,000 in life insurance premiums; options to purchase 7.55 million shares of Worlds Inc. common stock at an exercise price of  $0.076$0.25 per share, all2 million of which vested on August 30, 2012;28, 2018, 1.5 million shall vest on August 28, 2019 and the remaining 1.5 million shall vest on August 28, 2020 ; a death benefit of at least $2 million dollars; and a payment equal to 2.99 times his base amount (as defined in the agreement) in the event of a Change of Control (as defined in the agreement).  The option portion of Mr. Kidrin’s employment agreement has expired and has been replace by an option agreement giving Mr. Kidrin the option to purchase 25,000,000 million shares of Worlds Inc. common stock at an exercise price of $0.03 per share, all of which vest on October 1, 2017. The remaining parts of the agreement have been renewed by Mr. Kidrin for one year. The agreement also provides that Mr. Kidrin can be terminated for cause (as defined in the agreement) and that he is subject to restrictive covenants for 12 months after termination.   

(11)
Table of Contents

NOTE 6 - RELATED PARTY TRANSACTIONS

The Company paid $150,000 in notes payables with accrued interest to related parties during the six months ended June 30, 2019.

The balance in the accrued expense attributable to related parties is $74,312 and $341,624 at June 30, 2020 and December 31, 2019, respectively. 

 

NOTE 7 - RELATED PARTY TRANSACTIONS

On May 16, 2011, the Company transferred, through a spin-off to its then wholly owned subsidiary, Worlds Online Inc., the majority of its operations and related operational assets. The Company retained its patent portfolio which it intends to continue to increase and to more aggressively enforce against alleged infringers.

Due to and due from related party accounts is comprised of cash payments for operating expenses made by Worlds Online Inc. on behalf of Worlds Inc. or made by Worlds Inc on behalf of Worlds Online Inc. The balance at September 30, 2017 is a due from related party of $10,095 and the balance on December 31, 2016 is a due to related party of $5,053.

NOTE 8 - PATENTS

Worlds Inc. currently has nine patents, 6,219,045 - 7,181,690 - 7,493,558 – 7,945,856, - 8,082,501, – 8,145,998 – 8,161,383, – 8,407,592 and 8,640,028. On March 30, 2012, the Company filed a patent infringement lawsuit against Activision Bizzard Inc., Blizzard Entertainment Inc. and Activision Publishing Inc. in the United States District Court for the District of Massachusetts. Susman GodfreyOn September 20, 2019, the Company filed a lawsuit against Linden Research, Inc. in the US District court for the District of Delaware. Davidson, Berquist, Jackon & Gowdey LLP is lead counsel for the Company. The costs to prosecute those parties that the Company and our legal counsel believe to be infringing on said patents were capitalized under patents until a resolution is reached.

 

There can be no assurance that the Company will be successful in its ability to prosecute its IP portfolio or that we will be able to acquire additional patents.

NOTE 8 – ACCRUED EXPENSES

Accrued expenses is comprised of $74,312 owed to related parties. $205,000 is related to a judgment against the Company relating to unpaid consulting services dating back to April of 2001. $1,305,009 is related to old accruals for which the statute of limitations has passed and therefore the Company does not expect it will ever have to repay those amounts. The balance of $52,219 is related to accruals for recurring operating expenses.

 

NOTE 9 – SALE OF MARKETABLE SECURITIESCONVERTIBLE NOTE RECEIVABLE – RELATED PARTY

 

When Worlds Inc. spun off Worlds Online Inc.The Company made an investment in January 2011,the form of a convertible note in the amount of $200,000 to Canadian American Standard Hemp (CASH). The convertible note has a 7% annual interest rate and matures in 2 years. Interest and principle is payable at maturity. The note can be converted at any time and either all or part of the amount due can be converted into the borrowers equity at a price of $0.50 per share. If converted into common stock, the Company retained 5,936,115would own 1% of CASH based upon current number of CASH shares outstanding. Messrs. Kidrin, Toboroff and Christos are Directors of common stockCASH and Mr. Kidrin is the CEO and Mr. Ryan is the CFO of CASH.

During the six months ended June 30, 2020, the Company earned $7,078 in Worlds Online Inc. Those shares were retainedinterest on the books of thenote.

NOTE 10 – SUBSEQUENT EVENTS

The Company with a book value of $0. During the quarter the Company sold 120,472 shares at an average price of $0.49 per share raising $58,654.57. The proceeds from the sale was treated as a gain on sale of marketable securities in the financial statements.

reviewed for subsequent events and there are none to report.

 (12)12 
Table of Contents   

Item 2. Management's Discussions and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

 

When used in this Form 10-Q and in other filings by the Company with the Commission, the words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," “hope”, "may," "plan," "predict," "project," "will" or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward looking statements, each of which speak only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The Company has no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

 

These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different. These factors include, but are not limited to, changes that may occur to general economic and business conditions;conditions resulting from changes in political, social and economic conditions (whether or not related to terrorism, war, pandemic, weather, environmental or other factors) in the jurisdictions in which we operate;operate and changes to regulations that pertain to our operations; changes in technology that render our technology relatively inferior, obsolete or more expensive compared to others; delays in the delivery of broadband capacity to the homes and offices of persons who license our technology; general disruptions to Internet service; and the loss of customer faith in the Internet as a means of commerce.operations.

 

The following discussion should be read in conjunction with the unaudited financial statements and related notes which are included under Item 1.

 

We do not undertake to update our forward-looking statements or risk factors to reflect future events or circumstances.

 

Overview

 

General

 

Starting in mid-2001 we were not able to generate enough revenue to sustain full operations and other sources of capital were not available. As a result, we have had to significantly curtail our operations since that time and at times almost halt them all together. Since mid-2007, as more funds became available from our financings, we were able to increase operations and become more active operationally.

On May 16, 2011, we transferred, through a spin-off to our then wholly owned subsidiary, Worlds Online Inc. (currently callednamed MariMed Inc.), the majority of our operations and related operational assets. We retained our patent portfolio which we intend to continue to increase and to more aggressively enforce against alleged infringers. We also entered into a License Agreement with Worlds OnlineMariMed Inc. to sublicense patented technologies.technologies, which agreement has since expired.

 

At present, the Company’s business is the enforcement and expansion of its patent portfolio and its anticipated sources of revenue after the spin off will be from any revenue that may be generated from enforcing its patents.

13
Table of Contents

 

Revenues

 

We generated no revenue during the quarter because we transferred the operations of the Company to Worlds Online Inc. and our other anticipated revenue generation streams did not producereceive any incomecourt awards or settlements during the quarter.

 

Expenses

 

We classify our expenses into two broad groups:

 

 • Cost of revenues; and

 

 • selling, general and administration.

(13)
Table of Contents

 

Liquidity and Capital Resources

 

We have had to limit our operations since mid 2001 due to a lack of liquidity.  However, we were able to issue equity and convertible debt in the last few years and raise small amounts of capital from time to time that, prior to the spinoff, was used to enable us to begin upgrading our technology, develop new products and actively solicit additional business, and more recently to protect, increase and enforce our patent portfolio.  WeAlthough we have been able to generate funds through our sale of shares of MariMed Inc., we continue to pursue additional sources of capital though we have no current arrangements with respect to, or sources of, additional financing at this time and there can be no assurance that any such financing will become available. If we cannot raise additional capital, form an alliance of some nature with another entity, raise more funds through the sale of shares of MariMed Inc., or start to generate sufficient revenues, we may needbe unable to once again scale back operations.purchase additional patents or otherwise expand operations through acquisition or otherwise. 

  

RESULTS OF OPERATIONS

 

Our net revenues for each of the threesix months ended SeptemberJune 30, 20172020 and 20162019 were $0.  All the operations were transferred over to Worlds Online Inc. in the spin off. The Company’s future sources of revenue after the spin off are anticipated to be from enforcing our patents in litigation or otherwise.

 

Three months ended SeptemberJune 30, 20172020 compared to the three months ended SeptemberJune 30, 20162019

 

Revenue is $0 for the three months ended SeptemberJune 30, 20172020 and 2016.2019. All the operations were transferred over to Worlds Online Inc. in the spin off. The business up to the spin off continued to run in a severely diminished mode due to the lack of liquidity. Post spin off we still need to raise a sufficient amount of capital to provide the resources required that would enable us to expand our business.

Cost of revenues is $0 in the three months ended June 30, 2020 and 2019.

Selling general and administrative (SG&A) expenses increased by $81,825 from $161,073 to $242,898 for the three months ended June 30, 2019 and 2020, respectively. Increase is due to an increase in legal costs related to the patent infringement litigation cases.

Salaries and related increased by $3,662 to $54,570 from $50,908 for the three months ended June 30, 2020 and 2019, respectively. The increase is due to the increase in the CEO’s salary based on the terms of his 2018 employment agreement.

For the three months ended June 30, 2020, the Company recorded an option expense of $106,467, equal to the increase in estimated fair value of the unvested options at June 30, 2020. For the three months ended June 30, 2019, the Company recorded $35,298 of option expense. 

For the three months ended June 30, 2020 the Company had an interest expense of $18,918 and for the three months ended June 30, 2019 the Company had an interest expense of $0.

For the three months ended June 30, 2020 the Company had interest income of $3,539. For the three months ended June 30, 2019 the Company had no interest income.

As a result of the foregoing, we realized a net loss of $419,314 for the three months ended June 30, 2019 compared to a net loss of $247,279 for the three months ended June 30, 2019.

Six months ended June 30, 2020 compared to six months ended June 30, 2019

Revenue is $0 for the six months ended June 30, 2020 and 2019. All the operations were transferred over to Worlds Online Inc. in the spin off. The business up to the spin off continued to run in a severely diminished mode due to the lack of liquidity. Post spin off we still need to raise a sufficient amount of capital to provide the resources required that would enable us to continue running the business.

 

Cost of revenues is $0 in the threesix months ended SeptemberJune 30, 20172020 and 2016.2019.

 

Selling general and administrative (SG&A) expenses decreasedincreased by $57,651$68,156 from $136,448$346,672 to $78,797$414,828 for the threesix months ended SeptemberJune 30, 20162019 and 2017,2020, respectively. DecreaseThe increase is due to professional service fees surroundingan increase in legal costs related to the patent infringement lawsuit and raising funds last year with limited activity this year.

litigation cases.  

Salaries and related increased by $3,882$4,971 to $64,054$107,236 from $60,172$102,265 for the threesix months ended SeptemberJune 30, 20172020 and 2016,2019, respectively. The increase is due to anthe increase in the CEO’s salary based on the terms of his 2018 employment agreement.

 

For the threesix months ended SeptemberJune 30, 2017,2020, the Company had a gain on salerecorded an option expense of marketable securities$187,546, equal to the increase in estimated fair value of $58,655 from the saleunvested options at June 30, 2020. For the six months ended June 30, 2019, the Company recorded $54,471 of Worlds Online Inc. common stock.option expense. 

 

For the threesix months ended SeptemberJune 30, 2016, we had a warrant expense of $1,109,440.

For the three months ended September 30, 2017,2020, the Company had interest expense of $11,342 compared to an$37,837. For the six months ended June 30, 2019, the Company had interest expense of $21,536 for the three months ended September 30, 2016.$8,015.

 

For the threesix months ended SeptemberJune 30, 2016,2020 the Company had a gain on change in fair valueinterest income of derivative liability of $71,860 related to$7,078. For the issuance of secured convertible notes andsix months ended June 30, 2019 the outstanding options that are required to be recorded as a derivative liability.Company had no interest income.

 

As a result of the foregoing, we realized a net loss of $95,540$740,369 for the threesix months ended SeptemberJune 30, 20172020 compared to a net loss of $1,255,340$511,423 in the threesix months ended SeptemberJune 30, 2016.

2019.

 (14)14 
Table of Contents   

 

 

Nine months ended September 30, 2017 compared to nine months ended September 30, 2016

Revenue is $0 for the nine months ended September 30, 2017 and 2016. All the operations were transferred over to Worlds Online Inc. in the spin off. The business up to the spin off continued to run in a severely diminished mode due to the lack of liquidity. Post spin off we still need to raise a sufficient amount of capital to provide the resources required that would enable us to continue running the business.

Cost of revenues is $0 in the nine months ended September 30, 2017 and 2016.

Selling general and administrative (SG&A) expenses decreased by $207,090 from $539,256 to $332,166 for the nine months ended September 30, 2016 and 2017, respectively. Decrease is due to a decrease in professional service fees related to the patent infringement lawsuit and raising of funds last year compared to limited activity this year.

Salaries and related increased by $15,528 to $192,163 from $176,635 for the nine months ended September 30, 2017 and 2016, respectively. The increase is due to an increase in the CEO’s salary based on the terms of his employment agreement.

For the nine months ended September 30, 2017, the Company had a gain on sale of marketable securities of $58,655 from the sale of Worlds Online Inc. common stock.

For the nine months ended September 30, 2016, we had a warrant expense of $1,109,440.

For the nine months ended September 30, 2017, the Company had interest expense of $33,658 compared to $75,796 for the comparable period in 2016.

For the nine months ended September 30, 2016, the Company had a loss on change in fair value of derivative liability of $364,191. The derivative liabilities are in connection with the issuance of the secured convertible notes which are required to be recorded as a derivative liability and for 2016, the options which are required to be recorded as a derivative liability.

As a result of the foregoing, we realized a net loss of $504,726 for the nine months ended September 30, 2017 compared to a net loss of $2,264,922 in the nine months ended September 30, 2016.

(15)
Table of Contents

  

  

Liquidity and Capital Resources

 

At SeptemberJune 30, 2017,2020, our cash and cash equivalents were $37,976.  During$1,038,759. The Company did not raise any funds or sell any shares of stock that the nineCompany retained in the spin off company MariMed Inc. during the six months ended SeptemberJune 30, 2017, we raised an aggregate of $292,800 from warrants being exercised2020. The Company used $525,007 in cash to pay for common stock and $58,655 fromoperating expenses during the sale of marketable securities.six months ended June 30, 2020.

 

DuringAt June 30, 2019, our cash and cash equivalents were $2,265,002. The Company did not raise any funds or sell any shares of stock that the nineCompany retained in the spin off company MariMed Inc. during the six months ended SeptemberJune 30, 2016, we raised an aggregate of $290,000 from issuing2019. The Company repaid $750,000 in notes payable $156,500 was raised from a convertible note payable; and an aggregatenotes payable related party plus accrued interest of $350,000 from issuing thirty five million shares of common stock.$189,118. The Company used approximately $831,118 in cash to pay for operating expenses during the six months ended June 30, 2019.

 

There were no capital expenditures in the nine months ended September 30, 2017 or in the nine months ended September 30, 2016.

Historically, ourOur primary cash requirements have been used to fund the cost of operations development of our productsand lawsuits, and patent protection,enforcement, with additional funds having been used in connection with the exploration of new business lines.

 

The funds raised in our 2017 and 2016 financings were and will be used to enhance our patent portfolio, pay salaries to management and pay professional fees to our attorneys and auditors to prepare and file reports with the Securities and Exchange Commission.  We hope to raise additional funds to be used for further developing our portfolio of patents and to document our technology in order to enforce our patents where there is infringement.  No assurances can be given that we will be able to raise any additional funds.  

 

Item 4. Controls And Procedures

 

As of SeptemberJune 30, 2017,2020, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of SeptemberJune 30, 2017. The above statement notwithstanding, you are cautioned that no system is foolproof.2020.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter covered by this report there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 (16)15 
Table of Contents   

 

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The Federal case beforeCompany is seeking damages for patent infringement of the Company’s patents in two active proceedings.  The first proceeding, filed by the Company against Activision Blizzard, Inc., Blizzard Entertainment, Inc., and Activision Publishing, Inc. in the U.S. District Court for the District of Massachusetts in 2012, has been stayed since 2015 and was recently unstayed by Judge Denise Casper has beenCasper.  The Company also filed a complaint for patent infringement against Linden Research, Inc., d/b/a Linden Lab in the U.S. District Court for the District of Delaware in 2019.

1.Company’s Lawsuit Against Activision Entities

The Company's lawsuit against the Activision entities, filed in 2012, was stayed in 2015 pending the outcome of the IPR appeal to the United States Court of Appeals for the Federal Circuit (“CAFC”).

On May 26, 2015, Bungie, Inc. filed three Petitions forsix Inter Partes Review with(“IPR”) petitions filed by Bungie, Inc. to the U.S. Patent & Trademark Office (“USPTO”), and specifically, theOffice's Patent Trial and Appeal Board (“PTAB”).  These Petitions for Inter Partes Review, Case Nos. IPR2015-01264, -01268, and -01269 respectively contained validity challenges of three U.S. patents assigned to the Company.  On June 1, 2015, Bungie, Inc. filed three additional Petitions for Inter Partes ReviewThose IPR proceedings were concluded in Company's favor on January 14, 2020, with the USPTO,majority of the challenged claims surviving Bungie's challenges.  Returning to its District Court litigation, the Company asked that Judge Casper lift the stay and specificallyallow the PTAB. The PetitionCompany to proceed in its lawsuit for Inter Partes Review, Case No. IPR201501319 contained validity challengespatent infringement of one additional U.S. patent assigned to the Company. The Petitions for Inter Partes Review, Case Nos. IPR2015-01321 and 01325 contained validity challenges of one additional U.S. patent assigned to the Company. In each Inter Partes Review, Bungie, Inc. was asking the PTAB to cancel issued claims from the Company’s patents.

The Company’s legal counsel represented the Company before the USPTO with regard to these six Petitions for Inter Partes Review, Case Nos. IPR2015-01264, -01268, -01269, -01319, -01321, and -01325, institutedpatents against the five U.S. patents assigned to the Company.  The Company vigorously contested each Inter Partes Review.  

On November 10, 2016, the PTAB issued its final written decision in IPR201501264, canceling claim 1 of Company’s U.S. Patent No. 7,945,856.Activision entities.

 

On November 30, 2016,April 17, 2020, Judge Casper issued an Order unstaying the PTAB issued itslitigation and setting a pre-trial schedule, with a final written decisionpretrial conference and trial to occur at a date to be determined after June 24, 2021.  The Court's schedule is as follows:

Fact discovery resumes April 21, 2020. Date by which counsel to meet/confer regarding estoppel issue May 5, 2020. Worlds' narrowed election of asserted claims May 5, 2020. Activision's 35 U.S.C. 101 motion due May 19, 2020. Worlds' opposition to the 35 U.S.C. 101 motion due June 9, 2020. Activision's 35 U.S.C. 101 reply brief due June 23, 2020. Hearing on Activision's 35 U.S.C. 101 motion July 22, 2020 at 3:00 p.m.

Close of Fact Discovery January 14, 2021. Worlds' Narrowing of Asserted Claims (No more than 3 claims per patent; 15 claims maximum) January 21, 2021. Activision's Narrowing of Prior Art (No more than 7 prior art references per patent; 20 references total) February 4, 2021.

Status conference February 8, 2021 at 2:00 p.m. Opening expert reports February 18, 2021. Rebuttal expert reports March 25, 2021. Close of Expert Discovery April 15, 2021.

Dispositive motions (can address estoppel issue If still disputed)/Daubert motions due May 13, 2021. Opposition to Dispositive motions/Daubert motions due June 10, 2021. Reply briefs in IPR201501268, canceling claims 1-3, 5-7, 10-12, 14, 15, 17,support of Dispositive motions/Daubert motions due June 24, 2021. Hearing on dispositive motions/Daubert hearing TBD.  Final Election deadlines and 19Final Pretrial Conference TBD.

2.Company’s Lawsuit Against Linden Research, Inc. d/b/a Linden Lab

On September 20, 2019, the Company filed a lawsuit against Linden Research, Inc., d/b/a Linden Lab (“Linden”) in the U.S. District Court for the District of Delaware for patent infringement of the Company’s U.S. Patent No. 7,181,690.  Of the claims reviewed, the PTAB did not cancel claims 4, 8, 13, and 16. 

On November 28, 2016, the PTAB issued its final written decision in IPR201501269, canceling claims 4, 6, 8, and 9 of Company’s U.S. Patent No. 7,493,558. Of the claims reviewed, the PTAB did not cancel claims 5 and 7. 

This case was assigned to Judge Maryellen Noreika.  On December 6, 2016,2, 2019, Linden answered the PTAB issued its final written decision in IPR201501319, canceling claims 1-8, 10, 12, and 14-16 of Company’s U.S. Patent No. 8,082,501.

On November 28, 2016, the PTAB issued its final written decision in IPR201501321, canceling claims 1-3, 7, 8, 12-18, and 20 of Company’s U.S. Patent No. 8,145,998.

On November 28, 2016, the PTAB issued its final written decision in IPR201501325, canceling claims 1 and 20 of Company’s U.S. Patent No. 8,145,998.  Of the claims reviewed, the PTAB did not cancel claims 2-3, 7, 8, and 11-18 in this proceeding. 

The Company did not appeal the final written decisions in IPR2015-01268, IPR201501269, and IPR2015-01325. 

Complaint, denying that it has committed patent infringement.  On January 12, 2017, February 7, 2017,8, 2020, the Court entered a Scheduling Order, setting deadlines for Fact Discovery and Contentions, Claim Construction, Expert Discovery, Summary Judgment, and Trial Phase.  The scheduled trial date is January 30, 2017, respectively, Company appealed the outcomes in IPR2015-01264, IPR2015-01319, and IPR2015-01321 to the United States Court of Appeals for the Federal Circuit (“CAFC”).  These three cases have been consolidated.31, 2022.

The company filed formal appeal briefs with the United States Court of Appeals for the Federal Circuit (“CAFC”) on June 26, 2017.

On June 19, 2017 Appelle, Bungie Inc., filed an extension request to respond which the CAFC granted on June 27, 2017. 

(17)
Table of Contents

 

Item 1A. Risk Factors

We are not obligated to disclose our risk factors in this report, however, limited information regarding our risk factors appears in Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the caption “Forward-Looking Statements” contained in this Quarterly Report on Form 10-Q and in “Item 1A. RISK FACTORS” of our 20152019 Annual Report on Form 10-K. There have been no material changes from the risk factors previously disclosed in our 20152019 Annual Report on Form 10-K.

The above notwithstanding, we are mindful of the COVID-19 pandemic currently sweeping the world in general and in particular the United States. Inasmuch as our business model does not rely on sales of a product or services or consumer access thereto, we do not believe that we will be negatively impacted by the pandemic and the economic havoc it is currently wreaking on the economies of the United States and the world. Having said that, it is possible that if the pandemic continues for an extended period of time and/or recurs again in the future, it may cause delays in the prosecution of the Company’s lawsuits.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None. 

During the nine months ended September 30, 2017 we raised an aggregate of $292,800 from warrants being exercised for common stock.

During the nine months ended September 30, 2016, we raised an aggregate of $350,000 from issuing thirty five million shares of common stock to accredited investors in exempt private offerings without the use of public advertising or the payment of commissions. During the nine months ended September 30, 2016, we raised an aggregate of $446,500 from issuing notes payable and convertible notes payable to accredited investors in exempt private offerings without the use of public advertising or the payment of commissions.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosure

Not applicable. 

Item 5. Other Information

 

None.

16
Table of Contents

 

Item 6. Exhibits

 

 3.1Certificate of Incorporation (a)
3.2By-Laws Restated as Amended (b)
31.1 Certification of Chief Executive Officer
    
 31.2 Certification of Chief Financial Officer
    
 32.1 Statement required by 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
    
 32.2 Statement required by 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.2002.
    
 101.INS 101.INS* XBRL Instance Document
    
 101.SCH 101.SCH*XBRL Taxonomy Extension Schema
    
 101.CAL 101.CAL*XBRL Taxonomy Extension Calculation Linkbase
    
 101.DEF 101.DEF*XBRL Taxonomy Extension Definition Linkbase
    
 101.LAB 101.LAB*XBRL Taxonomy Extension Label Linkbase
    
 101.PRE 101.PRE*XBRL Taxonomy Extension Presentation Linkbase

 

(a)Filed previously with the Proxy Statement Form DEF 14A on May, 19, 2010, as amended as described in Proxy Statements on Form DEF 14A filed on June 7, 2013 and May 17, 2016, and incorporated herein by reference.
(b)Filed previously with the Proxy Statement Form DEF 14A on May, 19, 2010, and incorporated herein by reference.

 

 (18)17 
Table of Contents   

 

  

SIGNATURES

 

SIGNATURES

In accordance with the requirements of the Exchange Act, the Registrant caused this Report to be signed on its behalf by the undersigned thereto duly authorized.

Date: November 14, 2017August 12, 2020

WORLDS INC.

 

By: /s/Thomas Kidrin

Thomas Kidrin

President and CEO

 

By: /s/Christopher Ryan

Christopher Ryan

Chief Financial Officer 

 (19)18 
Table of Contents   

 

 INDEX TO EXHIBITS

 

 Exhibit No.  Description
 3.1  
31.1CertificationCertificate of Chief Executive OfficerIncorporation (a)
     
 31.23.2  Certification of Chief Financial OfficerBy - Laws Restated as Amended (b)
     
 32.131.1  Certification of Chief Executive Officer
31.2Certification of Chief Financial Officer
32.1Statement required by 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
     
 32.2  Statement required by 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.
     
  101.INS101.INS* XBRL   Instance Document
     
  101.SCH101.SCH* XBRL   Taxonomy Extension Schema
     
  101.CAL101.CAL* XBRL   Taxonomy Extension Calculation Linkbase
     
  101.DEF101.DEF* XBRL   Taxonomy Extension Definition Linkbase
     
  101.LAB101.LAB* XBRL   Taxonomy Extension Label Linkbase
     
  101.PRE101.PRE* XBRL   Taxonomy Extension Presentation Linkbase

 

(a)Filed previously with the Proxy Statement Form DEF 14A on May, 19, 2010, as amended as described in Proxy Statements on Form DEF 14A filed on June 7, 2013 and May 17, 2016, and incorporated herein by reference.
(b)Filed previously with the Proxy Statement Form DEF 14A on May, 19, 2010, and incorporated herein by reference.

 

 (20)19 
Table of Contents